RTW Biotech Opportunities (LON:RTW) Stock Price Up 0.4% – What’s Next?

Shares of RTW Biotech Opportunities (LON:RTW) shot up 0.4% on Tuesday. The company traded as high as GBX 2.36 and last traded at GBX 2.33. Approximately 742,877 shares traded hands during mid-day trading, an increase of 13% from the average session volume of 655,721 shares. The stock had previously closed at GBX 2.32.

RTW Biotech Opportunities Price Performance

The stock has a market cap of £7.52 million, a price-to-earnings ratio of 0.04 and a beta of 0.77. The company has a debt-to-equity ratio of 22.80, a quick ratio of 0.81 and a current ratio of 0.26. The company has a 50-day simple moving average of GBX 2.45 and a two-hundred day simple moving average of GBX 2.29.

About RTW Biotech Opportunities

RTW Biotech Opportunities Ltd (LSE: RTW) is an investment fund focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. Driven by a long-term approach to support innovative businesses, RTW Bio invests in companies developing next-generation therapies and technologies that can significantly improve patients’ lives. RTW Bio is managed by RTW Investments, LP, a leading healthcare-focused entrepreneurial investment firm with deep scientific expertise and a strong track record of supporting companies developing life-changing therapies.